Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Management

 

John E. Bennett
Head of Business Development

Mr. Bennett most recently was Vice President of Corporate Development for YM BioSciences in Berwyn, PA.  Prior to that, Mr. Bennett was Senior Vice President Business Development for Aventis Behring responsible for global licensing activities and held various senior positions at Rhone-Poulenc Rorer in business development and finance.  Mr. Bennett has more than 20 years experience in the pharmaceutical industry in licensing, mergers and acquisitions and finance, holds a bachelor’s degree in accounting from St. Joseph’s University and is a Certified Public Accountant.

< return

 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.